Wedbush Securities Inc Oncolytics Biotech Inc Transaction History

Wedbush Securities Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.71 - $4.03 $190,836 - $449,748	-111,600 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$1.58 - $2.15 $55,307 - $75,260	-35,005 Reduced 23.88%	111,600 $189,000
Q2 2020 Jul 16, 2020	BUY	$1.33 - $2.76 $135,527 - $281,244	101,900 Added 227.94%	146,605 $276,000
Q1 2020 Apr 17, 2020	BUY	$0.98 - $4.28 $43,810 - $191,337	44,705 New	44,705 $62,000

1.25M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $42.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.